Login

Hantz Group employs a holistic approach to provide clients with comprehensive financial, estate, and tax planning solutions. 00:10:00

Share On Facebook Share On Twitter

John Hantz - Chief Executive Officer - Hantz Holdings llc

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:00:00
Synergies and Challenges in the Implementation of Pathology AI Applications - Hammad A. Qureshi, PhD
00:10:00
We steward capital and companies to help the world flourish|JASON ILLIAN,CEO,Highmount Capital LLC
00:10:00
discuss the latest innovation in financial services|Charles Birnbaum,Partner,Bessemer Venture Partners
00:10:00
HealthBeacon is among four nominees in the Intelligent Automation - Best Use of RPA & Cognitive category, aiming to win the top award.
00:10:00
Sarama Resources' Strategic Plans and Investment Potential in 2020: Insights from the CEO at Cape Town Mining Conference
00:10:00
Dimensional: Implementing Finance Science in Investment Management
00:10:00
Helping entrepreneurs turn early-stage concepts into tomorrow's industry-leading companies|Matt Mosman,Partner,Pelion Venture Partners
00:10:00
Strategic Growth and Future Prospects in Precious Metals
00:10:00
Inheriting Prosperity: Inside The Wealth Conservancy | MYRA SALZER - CFP of The Wealth Conservancy, Inc.
00:10:00
Alamo Group President Advocates for Seguin Education Foundation Support | Jeff Leonard - President & Chief Executive Officer of Alamo Group, Inc.
00:10:00
The interviews feature Brian Spear of Sunrise Capital Investors and LP Investor Advisor Aleksey Chernobelskiy of Centrio Capital Partners.
00:10:00
Jean Case: Revolutionizing Investments for Profit and Impact | Jean Case - CEO of The Case Foundation

© 2026 Nehu